Biotech · Private company
Bioverativ Therapeutics Inc.
Track this companyFree. Adds Bioverativ Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials130 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- Advate®Phase 3 · Severe Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- BIIB031 (rFVIIIFc)Phase 3 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- Factor IX (rFIXFc)Phase 3 · Severe Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- Factor VIII (rFVIIIFc)Phase 3 · Severe Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- FIXPhase 3 · Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- FVIII (PK subgroup only)Phase 3 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- rFIXPhase 3 · Severe Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- rFIXFcPhase 3 · Severe Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- rFIXFcPhase 3 · Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- rFVIIIFcPhase 3 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- rFVIIIFcPhase 3 · Severe Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- non-Fc FIX replacement productsHemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- non-Fc FVIII replacement productsHemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- rFIXFcHemophilia AClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI TherapiesPHASE4 · COMPLETED · started Aug 29, 2017ClinicalTrials.gov NCT03103542 · fetched Nov 12, 2026
- Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) ScalePHASE3 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02502149 · fetched Nov 12, 2026
- Fc factOrs and Real-World hemophiliA Patient-ReporteD OutcomesTERMINATED · started Jul 1, 2015ClinicalTrials.gov NCT02392156 · fetched Nov 12, 2026
- Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell DiseaseCOMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02447627 · fetched Nov 12, 2026
- Pharmacokinetics of rFVIIIFc at Two Vial StrengthsPHASE1 · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02083965 · fetched Nov 12, 2026
- Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia APHASE3 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01458106 · fetched Nov 12, 2026
- Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia BPHASE3 · COMPLETED · started Jun 1, 2012ClinicalTrials.gov NCT01440946 · fetched Nov 12, 2026
- Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia BPHASE3 · COMPLETED · started Dec 8, 2011ClinicalTrials.gov NCT01425723 · fetched Nov 12, 2026
- Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia APHASE3 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT01454739 · fetched Nov 12, 2026
- Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia APHASE3 · COMPLETED · started Nov 1, 2010ClinicalTrials.gov NCT01181128 · fetched Nov 12, 2026
- Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia APHASE1 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01027377 · fetched Nov 12, 2026
- Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia BPHASE3 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01027364 · fetched Nov 12, 2026
- Phase I/IIa Study of FIXFc in Hemophilia B PatientsPHASE1 · COMPLETED · started Apr 1, 2008ClinicalTrials.gov NCT00716716 · fetched Nov 12, 2026